Trial intelligence / Profile preview

Topical fluorouracil plus microneedling for vitiligo lesions

IRCT20180602039939N1Phase 2Completed

Sponsor
Mashhad University of Medical Sciences
Start
Mar 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-blind trial of fluorouracil in Vitiligo (3 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Re-pigmentation percent, Re-pigmentation start time and 1 more. Started Mar 2021; status: completed.

02

Drugs

fluorouracil
03

Conditions

Vitiligo

Beyond the preview

Go deeper on IRCT20180602039939N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180602039939N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call